Two hidden histories in genomes: from herds to stem cells
Bison genomes recover diversity from before a population crash, while variants in two genes clarify a cellular route to inherited bone marrow failure.
Science··Morning
A measure from before the crash
When North American bison fell from tens of millions to a few hundred animals in the nineteenth century, conservation inherited an awkward question: what did today’s herds recover, and what could they not bring back? A UC Santa Cruz-led team combined 160 new genomes—115 ancient and 45 from the past century—with 52 published modern genomes. Spanning more than 20,000 years, the collection places living animals and diversity from before the crash on the same baseline. The findings place plains-bison ancestry in modern wood bison between 7 percent and 64 percent, while also finding the two groups substantially distinct. The authors’ case for managing them separately rests on measuring both historical mixing and the differences that remain. The same dataset reports cattle ancestry in about one-third of modern bison, where present at under 2 percent of the genome. Such detail makes the conservation point concrete by showing which lineages are measured against which period of history.[1]
The route inside a diagnosis
The Kyoto University report works at a far smaller scale and follows a related logic of comparison. Researchers link inherited variants in SLF2 and SMC5 to a distinct bone marrow failure syndrome and to predisposition to myelodysplastic syndrome. They made blood-forming progenitors from patient-derived induced pluripotent stem cells, then compared them with genetically corrected, otherwise matched control lines made with CRISPR-Cas9. The reported difference is that the variants activate p53 and are associated with premature ageing in haematopoietic stem cells. The evidence is cell-based and demonstrates no treatment in a patient. Locating the point at which a previously hard-to-name condition goes wrong matters for clinical classification and for the approaches that may later be tested. The study connects the two gene names with a traceable biological process that brings apparently scattered findings together.[2]
Comparison gives a genome meaning
The two studies address different problems and keep clinical implications and conservation decisions on their respective evidence bases. In each, genomic information gains meaning through a well-designed comparison. The bison work extends the time horizon of a management debate by comparing living herds with samples from before near-extinction. The bone marrow work ties a genetic variant to a cellular mechanism through comparison with corrected control cells. The design of the comparison gives the finding its force. A variant or an ancestry share shows which questions historical and biological comparisons can answer; it carries no role as fate or policy prescription. The next steps also differ—broader samples across time and geography for bison, and studies that connect the marrow mechanism to patients and clinical outcomes. A sound comparison lets a genome make previously hidden lines in history and disease legible.[1], [2]
